We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rx Competition, Generics Drive Down Medicare Rx Costs, HHS Says
Rx Competition, Generics Drive Down Medicare Rx Costs, HHS Says
February 7, 2006
Increased generic drug use and stronger-than-expected competition in the prescription drug market have driven down the overall costs of the Medicare Rx drug benefit, according to HHS officials.